The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...
Opioids like sufentanil and remifentanil during surgery may worsen post-surgery pain, highlighting the need for a review of ...
Pain management continues to be a priority animal welfare issue, particularly as updates to the beef cattle code of practice ...
On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...
Novant Health Inc. has opened a clinic in Stokesdale focused on acute and chronic pain management. The facility is located at 7779 N.C. 68, Suite 2A, near Stokesdale Town Park.
According to a systematic review and meta-analysis of 41 randomized clinical trials, involving nearly 5,000 children, NSAIDs, ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...